Home Tags PALISADE study

Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...

News Wire ~ 3rd Party Press Release - 2021/08/05 0

New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...

News Wire ~ 3rd Party Press Release - 2020/06/08 0

Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...

News Wire ~ 3rd Party Press Release - 2019/02/25 0

Aimmune to Submit FDA Application for Peanut OIT Candidate by End...

Dave Bloom - 2018/03/06 0

Results of Phase III Trial of Aimmune's Peanut OIT Therapy

Dave Bloom - 2018/02/20 0

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

Dave Bloom - 2018/01/08 0

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

Dave Bloom - 2017/05/17 0

Put Your School on the Map

Dave Bloom - 2024/07/31 0

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: PALISADE study